ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,360, issued on Aug. 26, was assigned to AVECTAS Ltd. (County Kildare, Ireland).
"Cell engineering platform" was invented by Michael Maguire (Dublin).
According to the abstract* released by the U.S. Patent & Trademark Office: "The current subject matter provides a cell engineering platform of a diagnostic and clinical use scale for vector-free and/or viral delivery of payload/cargo compounds and compositions into non-adherent cells. The platform achieves delivery to a large number of cells quickly in a closed system. Related apparatus, systems, techniques, articles and compositions are also described."
The patent was filed on May 31, 2019, under Application No. 17/059,769.
*For ...